Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the...

For Cancer Researchers, SynGlyphX Provides Added Visibility for Discovery Alexandria, Va, Aug. 01, 2017 (GLOBE NEWSWIRE) -- SynGlyphX® the leading provider of interactive data visualization and discovery technology and John Carroll University's College of Arts and...